Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 32.79M | $477.0M | 4.13% | -3.60M | 2026-06-30 |
| FMR LLC | 10.04M | $146.0M | 1.27% | -809.3K | 2026-06-30 |
| State Street Corp | 9.54M | $138.0M | 1.20% | +2.51M | 2026-06-30 |
| BlackRock, Inc. | 9.53M | $138.0M | 1.20% | -124.7K | 2026-06-30 |
| Vanguard Capital Management LLC | 5.73M | $83.0M | 0.72% | +22.7K | 2026-06-30 |
| UBS Group AG | 5.31M | $77.0M | 0.67% | +1.61M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 5.04M | $73.0M | 0.64% | -191.1K | 2026-06-30 |
| Goldman Sachs Group Inc | 4.51M | $65.0M | 0.57% | +4.20M | 2026-06-30 |
| Price T Rowe Associates Inc | 3.89M | $56.0M | 0.49% | -4.38M | 2026-06-30 |
| Point72 Asset Management, L.P. | 3.70M | $53.0M | 0.47% | +2.90M | 2026-06-30 |
